Labcorp was granted a patent for detecting abnormal lipoproteins.

{
  "signal_id": "0d2f131f-f9ff-564d-b92a-58dc8532a1cb",
  "signal_type": "patents-company",
  "signal_subtype": "patentGrant",
  "detected_at": "2026-09-23T14:59:23+00:00",
  "company": {
    "name": "Labcorp",
    "domain": "labcorp.com"
  },
  "data": {
    "cpc": [
      {
        "code": "G01N 33/92"
      },
      {
        "code": "G01N 24/00"
      },
      {
        "code": "G01N 35/00693"
      },
      {
        "code": "G01N 2035/00702"
      },
      {
        "code": "G01N 2800/52"
      }
    ],
    "tags": [
      "Intellectual Property",
      "Research & Development",
      "Medical Research",
      "Laboratory Operations"
    ],
    "detail": "In September 2026 Labcorp patented blood-testing technology for measuring abnormal lipoproteins in plasma and serum to support cardiovascular and metabolic analysis.",
    "summary": "Labcorp was granted a patent for detecting abnormal lipoproteins.",
    "event_at": "2026-09-22",
    "inventors": [
      {
        "name": "James D. Otvos",
        "status": "resolved",
        "is_primary": true,
        "linkedin_url": "https://www.linkedin.com/in/jim-otvos-143193207"
      },
      {
        "name": "Irina Shalaurova",
        "status": "resolved",
        "is_primary": false,
        "linkedin_url": "https://www.linkedin.com/in/irina-shalaurova-a218a4106"
      },
      {
        "name": "Alan Remaley",
        "status": "unresolved",
        "is_primary": false
      },
      {
        "name": "Maureen Sampson",
        "status": "unresolved",
        "is_primary": false
      },
      {
        "name": "Lita Freeman",
        "status": "unresolved",
        "is_primary": false
      }
    ],
    "event_kind": "grant_date",
    "grant_date": "2026-09-22",
    "source_url": "https://patents.google.com/patent/US12742792",
    "cpc_primary": {
      "code": "G01N 33/92"
    },
    "patent_title": "Methods and systems to detect and quantify the amount of LP-X and other abnormal lipoproteins in a biosample using NMR spectroscopy",
    "patent_number": "US12742792",
    "uspto_assignee": "Laboratory Corporation of America Holdings",
    "patent_abstract": "Described herein are methods and systems for the determination of constituents in biosamples by NMR spectroscopy and more specifically for the determination of lipoprotein constituents LP-X, LP-Y, and LP-Z in blood plasma and serum.",
    "precision_class": "structural",
    "invention_explanation": "A nuclear magnetic resonance test that identifies and measures unusual lipoprotein particles in a blood sample.",
    "technologies_mentioned": [
      "NMR spectroscopy",
      "lipoprotein analysis",
      "blood diagnostics"
    ]
  }
}

curl https://signals.autobound.ai/v1/signals/0d2f131f-f9ff-564d-b92a-58dc8532a1cb \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"labcorp.com","limit":20}'